| Bioactivity | CBP-501 is a cell-permeable and calmodulin-binding peptide that enhances the influx of platinum agents into tumor cells and tumor immunogenicity. CBP-501 can be utilized in cancer research[1]. |
| CAS | 565434-85-7 |
| Formula | C86H122F5N29O17 |
| Molar Mass | 1929.06 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Enzler T, et al. A multicenter, randomized phase 2 study to establish combinations of CBP501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma. Eur J Cancer. 2024 Apr;201:113950. |
CBP-501
CAS: 565434-85-7 F: C86H122F5N29O17 W: 1929.06
CBP-501 is a cell-permeable and calmodulin-binding peptide that enhances the influx of platinum agents into tumor cells
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.